Oncology Institute, Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Oncology Institute, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Oncology Institute, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
  • Oncology Institute, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$314K, a 253% decline year-over-year.
  • Oncology Institute, Inc. annual Income Tax Expense (Benefit) for 2023 was -$36K, a 85.2% increase from 2022.
  • Oncology Institute, Inc. annual Income Tax Expense (Benefit) for 2022 was -$243K, a 63.8% increase from 2021.
  • Oncology Institute, Inc. annual Income Tax Expense (Benefit) for 2021 was -$671K, a 36.1% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$36K +$207K +85.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$243K +$428K +63.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$671K -$178K -36.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$493K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.